Location History:
- Zürich, CH (2004)
- Zurich, CH (2005)
- Clayton, MO (US) (2014)
- St. Louis, MO (US) (2009 - 2016)
Company Filing History:
Years Active: 2004-2016
Title: Innovations by Shelly E Sakiyama-Elbert in Tissue Repair
Introduction
Shelly E Sakiyama-Elbert, based in St. Louis, MO, is a prominent inventor with a strong focus on biocompatible materials for medical applications. With a portfolio of five patents, her work significantly impacts the field of tissue engineering and regenerative medicine.
Latest Patents
Among her latest patents is the groundbreaking invention of a polymer nanofiber scaffold for a heparin/fibrin-based growth factor delivery system. This innovative growth factor delivery scaffold combines a heparin/fibrin-based delivery system (HBDS) with a polymer nanofiber backbone for effective tendon and ligament repair. The scaffold boasts improved surgical handling properties, surpassing the gelatinous consistency of previous systems. It effectively delivers mesenchymal cells while controlling the release of essential growth factors. Notably, this scaffold can be integrated into mesenchymal stem cell (MSC) therapy for flexor tendon repair, offering a biocompatible and non-cytotoxic solution. Additionally, it holds potential applications in the surgical repair of injuries to bone, muscle, cartilage, or other tissues.
Career Highlights
Shelly's career includes significant collaborations with leading academic institutions, including the Swiss Federal Institute of Technology (ETH) Zurich and the University of Zurich. This experience has contributed greatly to her expertise in developing innovative biomaterials for medical uses.
Collaborations
Shelly has worked alongside notable colleagues such as Jeffrey Alan Hubbell and Jason Schense, further enriching her research and development expertise in the field. These collaborations have facilitated the advancement of her innovative projects and have fostered a collaborative environment for scientific exploration.
Conclusion
Shelly E Sakiyama-Elbert continues to champion innovations in tissue repair through her pioneering inventions in growth factor delivery systems. Her commitment to integrating technology and biocompatibility helps pave the way for breakthroughs in regenerative medicine. With her substantial contributions, she inspires future generations of inventors and researchers in the medical field.
